¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Protein Interaction Mapping"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® protein ÇÑ±Û ´Ü¹éÁú
¼³¸í   
  Åº¼Ò, ¼ö¼Ò, »ê¼Ò, Áú¼Ò, È²À» ÇÔÀ¯Çϰí Àִ À¯±âÈ­ÇÕ¹°·Î, ¸ðµç ¼¼Æ÷ÀÇ ¿øÇüÁúÀ» ÀÌ·ç°í Àִ ±âº» ±¸¼º¹°ÁúÀÌ´Ù. ´Ü¹éÁúÀº ±× ´ÜÀ§ÀΠ¾Æ¹Ì³ë»êµéÀÌ ÆéƼµå°áÇÕ¿¡ ÀÇÇØ °áÇյǾî ÀÖÀ¸¸ç, º¸Åë 20°³ÀÇ ¾Æ¹Ì³ë»êµéÀÌ ´Ù¸¥ ¼ø¼­¿Í Á¶¼ºÀ» °¡Áö°í ¹è¿­µÇ¾î, µ¶Æ¯ÇÑ ÇϳªÀÇ ´Ü¹éÁúÀ» Çü¼ºÇϰԠµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • body surface mapping
    üǥ¸éÀüÀ§Áöµµ
  • brain mapping
    ³úÁöµµÈ­
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • color mapping
    »öÁöµµÈ­
  • chromosome mapping
    ¿°»öüÁöµµÈ­
  • gene mapping
    À¯ÀüÀÚÀ§Ä¡ÁöÁ¤, À¯ÀüÀÚÁöµµÀÛ¼º
  • MR mapping
    ÀÚ±â°ø¸íÁöµµÈ­
  • mapping
    ÁöµµÈ­, ÁöµµÀÛ¼º
  • spot mapping
    ȯÀڹ߻ýÁöµµÀÛ¼º
  • antigen-antibody interaction
    Ç׿øÇ×ü»óÈ£ÀÛ¿ë
  • additive interaction
    »ó°¡ÀÛ¿ë
  • binocular interaction
    µÎ´«»óÈ£ÀÛ¿ë, ¾ç¾È»óÈ£ÀÛ¿ë
  • cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ë
  • drug interaction
    ¾à¹°»óÈ£ÀÛ¿ë
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interaction
    »óÈ£ÀÛ¿ë
  • mapping
    ÁöµµÈ­
  • protein binding
    ´Ü¹é°áÇÕ
  • protein-losing enteropathy
    ´Ü¹é¼Ò½ÇâÀÚº´Áõ
  • protein
    ´Ü¹é, ´Ü¹éÁú
  • adherence protein
    ºÎÂø´Ü¹é
  • reserve protein
    ÀúÀå´Ü¹é
  • split-timed urine protein
    ½Ã°£´ëº°¿ä´Ü¹éÁ¤·®
  • structural protein
    ±¸Á¶´Ü¹é, ±¸Á¶´Ü¹éÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • body surface mapping
    üǥ¸éÀüÀ§µµ
  • brain function mapping
    ³ú±â´ÉÁöµµÈ­
  • color mapping
    »öÁöµµÈ­
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • gene mapping
    À¯ÀüÀÚÀ§Ä¡ÁöÁ¤, À¯ÀüÀÚÁöµµÀÛ¼º
  • mapping
    ÁöµµÈ­
  • MR mapping
    ÀÚ±â°ø¸íÁöµµÈ­
  • spot mapping
    ȯÀڹ߻ýÁöµµÀÛ¼º
  • additive interaction
    »ó°¡ÀÛ¿ë
  • antigen-antibody interaction
    Ç׿øÇ×ü¹ÝÀÀ
  • binocular interaction
    ¾ç¾È»óÈ£ÀÛ¿ë, µÎ´«»óÈ£ÀÛ¿ë
  • cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ë
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • drug interaction
    ¾à¹°»óÈ£ÀÛ¿ë
  • genetic interaction
    À¯Àü»óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MR mapping
    ÀÚ±â°ø¸í ÁöµµÈ­
  • J-coupling interaction
    J °áÇÕ »óÈ£ÀÛ¿ë
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • additive interaction
    »ó°¡(ßÓÊ¥)ÀÛ¿ë.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen antibody interaction
    Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
  • antigen-antibody interaction
    Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
  • genetic interaction
    À¯ÀüÀû »óÈ£ÀÛ¿ë
  • heme heme interaction
    Èû-Èû »óÈ£ÀÛ¿ë(¡­ßÓû»íÂéÄ).
  • heme heme interaction
    Çð-Çð »óÈ£ÀÛ¿ë(¡­ßÓû»íÂéÄ).
  • infant-mother interaction
    ¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
  • interaction
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
  • interaction
    »óÈ£ÀÛ¿ë
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • body surface mapping
    üǥ¸é(ÀüÀ§)µµ(ô÷øúØüï³êÈÓñ),½ÉÀüµµ Áöµµ(ãýï³Óñò¢Óñ).
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ(ô÷øúØüï³êÈÓñ).
  • brain function mapping
    ³ú±â´É ÁöµµÈ­
  • cardiac mapping
    ½ÉµµÇØ(ãýÓñú°), ½ÉÀ嵵ǥȭ(ãýíôÓñøúûù)
  • chromosome(s),mapping
    ÁöµµÈ­(ò¢Óñûù)
  • color Doppler flow mapping
    »ö µµÇ÷¯ Ç÷·ù ÁöµµÈ­
  • color doppler flow mapping
    »ö (ßä) µµÇ÷¯ Ç÷·ùÇ¥½Ã (úì×µøúãÆ)
  • color flow mapping
    »ö Ç÷·ù ÁöµµÈ­
  • color mapping
    »öÁ¶ ÁöµµÈ­
  • mapping
    ÁöµµÈ­
  • mapping test
    Áö¸®(ÇÐ)Àû ½ÃÇè(ò¢ìµùÊîÜ ãËúÐ).
  • mapping test
    Áö¸®(ÇÐ)Àû ½ÃÇè(ò¢ìµ(ùÊ)îÜ ãËúÐ).
  • spot mapping
    Á¡µµ¹ý.
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • additive interaction
    »ó°¡(ßÓÊ¥)ÀÛ¿ë.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Protein granule
    ´Ü¹éÁú°ú¸³
    [¿¾ ¿ë¾î] ´Ü¹éÁú°ú¸³
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adherence protein
    ºÎÂø´Ü¹éÁú
  • circumsporozoite protein (CSP)
    Æ÷ÀÚ¼Òü¸·´Ü¹éÁú
  • protein layer
    ´Ü¹éÁúÃþ
  • stage-specific protein
    ¹ßÀ°´Ü°èƯÀ̴ܹéÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • deletion mapping
    °á¼ÕÀÛµµ(ÌÀáßíÂÓñ)
  • denaturation mapping
    º¯¼º ÀÛµµ(ܨàõíÂÓñ)
  • fine-structure genetic mapping
    ¹Ì¼¼ ±¸Á¶(Ú°á¬Ï°ðã) À¯ÀüÀÚ ÀÛµµ(ë¶îîí­íÂÓñ)
  • fragment length mapping
    Á¶°¢ ±æÀÌ ÀÛµµ(íÂÓñ)
  • gene mapping
    À¯ÀüÀÚ ÀÛµµ(ë¶îîí­íÂÓñ)
  • R-loop mapping
    R-·çÇÁ ÀÛµµ(íÂÓñ)
  • S1 mapping
    S1 ÀÛµµ(íÂÓñ)
  • complementary interaction
    »óº¸¼º »óÈ£ÀÛ¿ë(ßÓÜÍàõßÓû»íÂéÄ)
  • crossed hydrophobic interaction immunoelectrophoresis ±³Â÷ ¼Ò¼ö¼º»óÈ£ÀÛ¿ë ¸é¿ªÀü±â¿µµ¿(Îßó©áÂâ©àõßÓû»íÂéÄØóæ¹ï³Ñ¨ç¶
    ÔÑ)
  • dipole-dipole interaction
    ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë(äªÐ¿í­äªÐ¿í­ßÓû»íÂéÄ)
  • dipole-induced dipole interaction
    ½Ö±ØÀÚÀ¯µµ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë(äªÐ¿í­ë¯ÓôäªÐ¿í­ßÓû»íÂéÄ)
  • hydrophobic interaction
    ¼Ò¼ö »óÈ£ÀÛ¿ë(áÂâ©ßÓû»íÂéÄ)
  • hydrophobic interaction chromatography
    ¼Ò¼ö »óÈ£ÀÛ¿ë(áÂâ©ßÓû»íÂéÄ) Å©·Î¸¶Åä±×·¡ÇÇ
  • ion-dipole interaction
    ÀÌ¿Â-½Ö±ØÀÚ(äªÐ¿í­) »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • ion induced dipole interaction
    "ÀÌ¿ÂÀ¯µµ(ë¯Óô) ½Ö±ØÀÚ(äªÐ¿í­), »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • brain function mapping
    ³ú±â´ÉÁöµµÈ­
  • color Doppler flow mapping
    »öµµÇ÷¯Ç÷·ùÁöµµÈ­
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • color mapping
    »öÁ¶ÁöµµÈ­
  • mapping
    Á¦µµ, ÁöµµÈ­
  • MR mapping
    ÀÚ±â°ø¸íÁöµµÈ­
  • dipolar interaction
    ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • dipole dipole interaction
    ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£ÀÛ¿ë
  • intermolecular dipole dipole interaction
    ºÐÀÚ°£½Ö±ØÀÚ°£»óÈ£ÀÛ¿ë
  • intramolecular dipole dipole interaction
    ºÐÀÚ³»½Ö±ØÀÚ°£»óÈ£ÀÛ¿ë
  • J-coupling interaction
    J°áÇÕ»óÈ£ÀÛ¿ë
  • proton electron dipole dipole interaction
    ¾çÀÚÀüÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • proton proton dipole dipole interaction
    ¾çÀÚ¾çÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • tissue interaction
    Á¶Á÷°£ÀÇ »óÈ£ÀÛ¿ë
  • Bence-Jones protein
    º¥½º-Á¸½º´Ü¹é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EMT emergency medical tag; emergency medical team; emergency medical technician; emergency medical treat...
HGM hog gastric mucosa; human gene mapping; human glucose monitoring
ISSI interview schedule for social interaction; Israeli Study of Surgical Infections
LALI lymphocyte antibody-lymphocytolytic interaction
MDIA multidimensional interaction analysis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BSPM Body surface potential mapping
CFM Color-flow mapping
SPM Statistical Parametric Mapping
SPM96 Statistical Parametric Mapping
CM consistent mapping
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
  • chromosome mapping
    ¿°»öü Áöµµ ÀÛ¼º
    ƯÁ¤ÀÇ ¿°»öü »ó¿¡ Àִ ƯÁ¤ÀÇ À¯ÀüÀÚ ºÎÀ§¸¦ °áÁ¤Çϰí, À¯ÀüÀÚÀÇ »ó´ëÀû À§Ä¡¸¦ ³ªÅ¸³»´Â ¿°»öü Áöµµ¸¦ ÀÛ¼ºÇÏ´Â °úÁ¤À» ¸»ÇÑ´Ù. ±â¹ýÀ¸·Î¼­´Â Åë°èÀû ºÐ¼®À» ÀÌ¿ëÇÏ´Â °¡°è ¿¬±¸, ü¼¼Æ÷ ±³Àâ, ¿°»öü °á½Ç ÁöµµÀÇ ÀÛ¼º µîÀ» Æ÷ÇÔÇÑ´Ù.
  • color Doppler flow mapping
    »ö µµÇ÷¯ Ç÷·ù ÁöµµÈ­
  • color mapping
    »öÁ¶ ÁöµµÈ­
  • mapping chromosome
    ÁöµµÈ­ ¿°»öü
    ¼­·Î ¿¬¼âµÇ¾î ÀÖ´Â À¯ÀüÀÚÀÇ °¢°¢ÀÇ À§Ä¡¸¦ ¿°»öü À§ÀÇ »ó´ëÀûÀÎ ¼ø¼­³ª °Å¸®¿¡ µû¶ó¼­ ÇÑ °¡´ÚÀÇ Á÷¼± À§¿¡ µµ½ÄÀûÀ¸·Î ±×·ÁÁø ¿°»öü.
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • additive interaction
    »ó°¡ ÀÛ¿ë
  • heme heme interaction
    Èû-Èû »óÈ£ÀÛ¿ë
  • high-power interaction
    °íÃâ·Â »óÈ£ ÀÛ¿ë
  • interaction
    »óÈ£ ÀÛ¿ë
    µÎ °³ ¶Ç´Â ±× ÀÌ»óÀÌ ¼­·Î ¼­·Î ÀÛ¿ëÇÏ´Â ¼ºÁú, »óųª °úÁ¤.
  • nonthermal interaction
    ºñ¿­ »óÈ£ÀÛ¿ë
  • photochemical interaction
    ±¤È­ÇÐ ¹ÝÀÀ
  • photothermal interaction
    ±¤¿­ ¹ÝÀÀ
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
DNA-protein interaction <molecular biology> Any complex that forms between a protein molecule and DNA.
Examples are nucleosomes (structures formed for the purpose of DNA storage) and any gene regulatory protein (a protein which regulates transcription by binding to a regulatory region on the DNA).
(09 Oct 1997)
apolar interaction <chemistry> The attractive force between molecules due to the close positioning of non-hydrophilic portions of the two molecules.
(09 Oct 1997)
hydrophobic interaction <chemistry> The attractive force between molecules due to the close positioning of non-hydrophilic portions of the two molecules.
(09 Oct 1997)
specimen interaction <microscopy> Reactions that occur inside the specimen when being struck with a beam of energetic electrons or ions.
(05 Aug 1998)
specimen interaction volume <microscopy> The volume inside the specimen in which all specimen interactions occur during electron beam irradiation.
(05 Aug 1998)
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
drug interaction <pharmacology> A chemical or physiologic reaction that can occur when two different medications are taken together and the interaction may affect the metabolism, effectiveness or toxicity of the other.
(18 Jul 2002)
interaction The quality, state or process of (two or more things) acting on each other.
(18 Nov 1997)
interaction process analysis In psychology, analysis of small group behaviour in terms of 12 specific categories, e.g., solidarity, tension release, agreement.
(05 Mar 2000)
body surface potential mapping Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in wolff-parkinson-white syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel.
(12 Dec 1998)
cardiac mapping A method by which local cardiac potentials are spatially depicted in an integrated manner as a function of time (isochrone map) or potential (isopotential map).
(05 Mar 2000)
gene mapping Determination of the relative positions of genes on a DNA molecule (chromosome or plasmid) and of the distance, in linkage units or physical units, between them.
(09 Oct 1997)
mapping See: gene mapping, linkage map, physical map.
(09 Oct 1997)
mapping function In linkage analysis, a formula that converts the recombination fraction (which is on the probability scale) into map distance (in morgans).
(05 Mar 2000)
mapping, gene Charting the positions of genes on chromosome and learning the distance, in linkage units or physical units, between genes.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Protein Interaction Mapping - »õâ Methods for determining interaction between proteins.
    Synonyms : Protein Interaction Maps, Interaction Map, Protein, Interaction Map, Protein-Protein, Interaction Mapping, Protein, Interaction Mappings, Protein, Interaction Maps, Protein, Interaction Maps, Protein-Protein, Map, Protein Interaction, Maps, Protein Interaction
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gene mapping
    À¯ÀüÀÚ Áöµµ(¿°»öü»óÀÇ À¯ÀüÀÚ ÀÚ¸®¸¦ °áÁ¤Çϱâ)
  • mapping
    Áöµµ Á¦ÀÛ;»ç»ó;ÇÔ¼ö 
  • interaction
    »óÈ£ÀÛ¿ë
  • drug interaction
    (¾à)¾à¹° »óÈ£ ÀÛ¿ë
  • interaction
    »óÈ£ÀÛ¿ë;»óÈ£ÀÇ ¿µÇâ
  • protein
    ´Ü¹éÁú
  • coat protein
    ÇǸ· ´Ü¹é
  • conjugated protein
    º¹ÇÕ ´Ü¹éÁú
  • fish protein concentrate
    ¾îÀ° ³óÃà ´Ü¹é
  • protein
    ´Ü¹éÁú;´Ü¹éÁúÀÇ(À» ÇÔÀ¯ÇÏ´Â). proteinic a.
  • protein clock
    ´Ü¹éÁú ½Ã°è(´Ü¹éÁú ÁøÈ­ ¼Óµµ¸¦ Á¶ÀýÇÏ´Â °¡¼³Àû ü³» ±â±¸)
  • repressor protein
    ¾ïÁ¦ ´Ü¹é(Á¦¾î À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ¸¸µé¾îÁö´Â ´Ü¹é)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á